<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03541876</url>
  </required_header>
  <id_info>
    <org_study_id>RC-P0058</org_study_id>
    <nct_id>NCT03541876</nct_id>
  </id_info>
  <brief_title>French Pediatric Helicobacter Pylori Observatory</brief_title>
  <acronym>GFHPP</acronym>
  <official_title>Data Collection for the Creation of the French Pediatric Helicobacter Pylori Observatory</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Lille Catholic University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Lille Catholic University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Helicobacter pylori is a major human pathogen associated with significant morbidity. The
      treatment oriented by the antibiogram or PCR (Polymerase Chain Reaction) should be privileged
      in children. However, the optimal treatment for the eradication of pediatric H. pylori
      infection is still not established.

      No French consensus conference on the management of H. pylori infection in children taking
      into account the epidemiological data available for this infection has been published. The
      description of diagnostic and therapeutic management procedures has not yet been specifically
      described according to the country of birth of children. The main objective is to collect
      data enabling the establishment of a French observatory of Helicobacter pylori in children in
      order to provide a national database.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 9, 2018</start_date>
  <completion_date type="Anticipated">February 2024</completion_date>
  <primary_completion_date type="Anticipated">February 2022</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>2 Years</target_duration>
  <primary_outcome>
    <measure>Diagnosis of H. pylori infection</measure>
    <time_frame>at inclusion</time_frame>
    <description>Child with confirmed H. pylori infection by direct diagnostic methods (Histology, Bacterial culture, PCR) on perendoscopic gastric biopsies</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Age</measure>
    <time_frame>at inclusion</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Sex</measure>
    <time_frame>at inclusion</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Country of birth</measure>
    <time_frame>at inclusion</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Clinical symptoms</measure>
    <time_frame>at inclusion, 3 and 6 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Microbiological diagnosis</measure>
    <time_frame>at inclusion, 3 and 6 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Endoscopic diagnosis</measure>
    <time_frame>at inclusion, 3 and 6 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Rates of bacterial resistance profiles</measure>
    <time_frame>at inclusion, at 3 and 6 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>antibiotic therapy</measure>
    <time_frame>at inclusion, 3 and 6 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Bacterial eradication rates</measure>
    <time_frame>3 and 6 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Side effects and tolerance of first and second line treatments</measure>
    <time_frame>3 and 6 months</time_frame>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Helicobacter Pylori Infection</condition>
  <arm_group>
    <arm_group_label>children with H. pylori infection</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Collection of data</intervention_name>
    <description>The following data will be collected by the physician :
sociodemographic profile (age, sex, country of birth of child and parents); clinical manifestations; endoscopic aspects (esophagus, duodenum, stomach); different methods of diagnosis of infection; different primary and secondary bacterial resistance profiles ; different first and second line therapeutic combinations; different first and second line bacterial eradication rates ; different signs of side effects and tolerance of first and second line treatments; different methods of bacterial eradication control.</description>
    <arm_group_label>children with H. pylori infection</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      gastric biopsy for histological analysis, culture of bacteria and Polymerase Chain Reaction
      (PCR)
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Children with confirmed diagnosis of H. pylori infection
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Child with confirmed H. pylori infection by direct diagnostic methods after
             periendoscopic gastric biopsies

          -  Age &lt; 18

          -  No opposition of at least one of the 2 parents to the use of health data for research
             purposes

        Exclusion Criteria:

          -  Child with confirmed H. pylori infection by indirect diagnostic methods
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nicolas Kalach, PR</last_name>
    <role>Principal Investigator</role>
    <affiliation>Lille Catholic University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Am√©lie Lansiaux, MD PhD</last_name>
    <phone>+33 320225269</phone>
    <email>lansiaux.amelie@ghicl.net</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Justine Monvoisin</last_name>
    <phone>+33 320223884</phone>
    <email>monvoisin.justine@ghicl.net</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Lille Catholic University</name>
      <address>
        <city>Lille</city>
        <zip>59000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>April 23, 2018</study_first_submitted>
  <study_first_submitted_qc>May 29, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">May 31, 2018</study_first_posted>
  <last_update_submitted>March 2, 2020</last_update_submitted>
  <last_update_submitted_qc>March 2, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 3, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>children</keyword>
  <keyword>treatment</keyword>
  <keyword>observatory</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

